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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Iowa News 
• Opioid News 
• Department Efforts 
 
Iowa News 
 
House File 2377: Signed by the Governor 
 
On May 14, 2018, Governor Reynolds signed House File 2377 into law.  Often referred to as the 
“Opioid Bill”, this legislation brings several changes which include: 
 
• Required prescriber registration and use of the Prescription Monitoring Program (PMP) 
prior to issuing an opioid prescription 
• Transmission of prescription information for controlled substances by a pharmacy to the 
PMP within one business day of dispensing 
• Adoption of a Good Samaritan law to provide certain protections for good-faith actions to 
seek medical assistance for an individual experiencing an overdose 
• Required provider education on the CDC Guideline for Prescribing Opioids for Chronic 
Pain  
• Adding naloxone administrations by first responders and doses dispensed by 
pharmacies as reportable to the PMP 
• Mandating the electronic prescribing of all prescriptions (both controlled and non-
controlled) beginning January 1, 2020 
• Granting the Board of Pharmacy the authority to generate and send "proactive 
notifications" that summarize a practitioner’s history of prescribing controlled substances 
Opioid News 
 
SAMHSA Releases Series of Fact Sheets on Prescription Pain Medication 
 
The Substance Abuse and Mental Health Services Administration (SAMHSA) has released a 
series of fact sheets on Rx Pain Medication. “Rx Pain Medications, Know the Options, Get the 
Facts” is a series of 13 fact sheets designed to increase awareness of the risks associated with 
prescription opioid use and misuse. The resource aims to help health care providers better 
understand the potential risks associated with opioid misuse, as well as signs of misuse to look 
for in patients, discussion of how to talk to patients, and other options for pain management. 
The publication also educates patients on alternative pain management options, discussion of 
risks associated with opioid misuse, and tips for safe storage and disposal, among other topics. 
 
To access the series of Fact Sheets, please click on the following link: SAMHSA 
 
 
 
Comprehensive Opioid Abuse Site-based Program (COAP) Grants Available 
 
The Bureau of Justice Assistance (BJA) recently announced funding opportunities for FY 2018.  
The grant program provides awards ranging from $100,000 to $1,500,000 for a 24-36 month 
project period to deliver financial and technical assistance to states, units of local government, 
and Indian tribal governments to plan, develop, and implement comprehensive efforts to 
identify, respond to, treat, and support those impacted by the opioid epidemic.  The six grant 
categories are: 
• Category 1:  First Responder Partnerships 
• Category 2:  Technology-Assisted Treatment Projects 
• Category 3:  System-Level Diversion Projects 
• Category 4:  Statewide Planning, Coordination, and Implementation Projects 
• Category 5:  Harold Rogers Prescription Drug Monitoring Program (PDMP) 
Implementation and Enhancement Projects 
• Category 6:  Public Safety, Behavioral Health, and Public Health Information Sharing 
Partnerships 
 
BJA anticipates making more than 160 grant awards.  Last year, Iowa received the Harold 
Rogers (category 5) grant.  Applications are due June 7, 2018.  For more information, please 
click on the following link: COAP 
 
First, Do No Harm 
 
Recently the National Academy of Medicine, at the request of the National Governors’ 
Association, brought together a group of experts representing the key leadership of the nation’s 
scientific, professional, and policy organizations to explore clinicians’ role to counter the opioid 
epidemic.  The result of the work is, First, Do No Harm: Marshalling Clinician Leadership to 
Counter the Opioid Epidemic. An excerpt from the publication:   
 
Approximately 5 million clinicians are actively delivering patient care in communities 
throughout the nation. The largest group is nurses, and the most referenced in the 
context of clinician engagement in pain management are physicians (there are 950,000 
licensed physicians) and nurse practitioners (about 220,000). But the pool of skilled and 
dedicated health professionals providing capacity and leadership to health initiatives in 
pain management and opioid crisis mitigation also includes dentists, psychologists, 
pharmacists, physician assistants, registered nurses, physical therapists, podiatrists, 
occupational therapists, dental hygienists, paramedical assistants, emergency medical 
technicians, and social workers, as well as others who assist them. All are important to 
successfully countering the opioid epidemic, whether through caring for persons 
prescribed opioid medications, providing assistance to those who need it, or rallying 
community action.  
 
To read the entire publication, please click on the following link: NAM  
 
Five Unintended Consequences of Addressing the Opioid Crisis 
 
With a focus on reducing the number of opioids being prescribed in the U.S., an unintended 
consequence has arisen.  In an article by Politico, the push for fewer opioid prescriptions at 
lower doses and for shorter periods has increased suffering for some pain patients including 
those near the end of life. The emphasis on opioids has also overshadowed other forms of 
substance abuse that require attention.  
 
To read the entire article, please click in the following link: Politico 
 
Department Efforts 
 
A Focus on IDPH Prevention Efforts 
 
The Bureau of Substance Abuse supports a variety of services that focus on prevention of 
opioid and prescription drug misuse. The bureau administers grants that support prevention 
services including the Comprehensive Substance Abuse Prevention Grant, the Strategic 
Prevention Framework for Prescription Drugs and the IDPH AmeriCorps Substance Abuse 
Prevention Program. 
 
Bureau-funded prevention services have focused on the non-sharing of prescription 
medications, safe storage and disposal of medications as well as prescriber education.  Funded 
agencies have also utilized the Strategic Prevention Framework (SPF) to most effectively plan 
prevention services to address opioids and to sustain positive outcomes.  The SPF is a five-step 
planning process to assist communities in addressing substance misuse.   
 
The bureau supports evidence-based programs and strategies that have shown effectiveness in 
addressing opioid misuse. Educational programs for youth and adults that positively impact 
opioid misuse include the Life Skills Training Program, Strengthening Families Program (for 
youth 10-14) as well as Generation Rx.  Educational services are also provided to encourage 
prescribers to use SAMHSA’s Overdose Prevention Toolkit and the CDC’s Guidelines for 
Prescribing Opioids for Chronic Pain.  Community education services focus on dissemination of 
research-informed media campaigns, including the “Prescription Drugs Are Still Drugs” media 
campaign available through the bureau.   
 
To help support and expand prevention services in communities, the bureau administers a grant 
to support AmeriCorps members addressing opioid misuse through community education and 
collaboration.  Currently, there are 12 members in 10 host site agencies statewide. 
 
For more information on these grants, please click on the following link: Prevention  
 
 
